- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04101344
Fiber Blends and Gut Microbiota (FB) (FB)
December 23, 2024 updated by: Washington University School of Medicine
Effect of Dietary Supplementation With Fiber Blends on the Gut Microbiota and Host Metabolome and Proteome
The purpose of this research study is to determine whether consuming snacks containing different blends of dietary fibers alters the type and number of bacteria found in your gut and improves markers of overall health.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All subjects will complete a 47-day, multi-phase feeding study to evaluate the effect of two snack prototypes containing two different fiber blends on gut community structure and features of host biological state (plasma proteome/ metabolome).
The information gained from this work will increase our understanding of the importance of specific dietary fibers in manipulating the composition of the gut microbiota in ways that may improve our metabolic health.
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- BMI ≥25.0 and ≤35.0 kg/m2
- ≥18 and ≤60 years
Exclusion Criteria:
- previous bariatric surgery
- significant organ system dysfunction (e.g., diabetes, severe pulmonary, kidney, liver or cardiovascular disease)
- cancer or cancer that has been in remission for <5 years
- major psychiatric illness
- inflammatory gastrointestinal disease
- pregnant or lactating women
- use of medications that are known to affect the study outcome measures and that cannot be temporarily discontinued for this study
- use of medications known to affect the composition of the gut microbiota within the last 30 days (most notably antibiotics)
- bowel movements <3 times per week
- vegans, vegetarians, those with lactose intolerance and/or severe allergies/aversions/sensitivities to foods and ingredients included in the prescribed meal plan
- persons who are not able to grant voluntary informed consent
- persons who are unable or unwilling to follow the study protocol or who, for any reason, the research team considers not an appropriate candidate for this study, including non-compliance with screening appointments or study visits.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fiber-blend
All participants will receive a two fiber-blend snack and then a four fiber-blend snack.
Stool, blood, and urine will be monitored for changes throughout the study.
|
All subjects will complete a 47-day, multi-phase feeding study to evaluate the effect of two snack prototypes containing two different fiber blends on gut community structure and features of host biological state (plasma proteome/ metabolome).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of fiber blend snacks on gut microbiota
Time Frame: 1 year
|
Stool samples will be analyzed to determine changes in type and number of gut microbiota.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of fiber blend snacks in blood and urine
Time Frame: 1 year
|
Blood and urine samples will be analyzed to assess how many proteins and metabolites are present in these samples before and after fiber snack supplementation.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 26, 2019
Primary Completion (Actual)
November 21, 2019
Study Completion (Actual)
June 1, 2020
Study Registration Dates
First Submitted
September 20, 2019
First Submitted That Met QC Criteria
September 20, 2019
First Posted (Actual)
September 24, 2019
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 23, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 201907041
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gut Microbiome
-
Ocean Spray Cranberries, Inc.RecruitingGut Microbiome | Vaginal Microbiome | Gut HealthUnited States
-
University of California, DavisCompletedGut Microbiome | Skin Microbiome | Gut Lipidome | Skin Lipidome | Blood LipidomeUnited States
-
University Hospital, AntwerpActive, not recruitingGut Microbiome | Intermittent Fasting | Vaginal MicrobiomeBelgium
-
State University of New York at BuffaloCompleted
-
Access Business GroupCompletedGut MicrobiomeUnited States
-
Institut National de la Santé Et de la Recherche...Recruiting
-
San Diego State UniversityRecruiting
-
University College CorkAIT Austrian Institute of Technology GmbHActive, not recruiting
-
Evolve BioSystems, Inc.University of California, DavisCompletedGut MicrobiomeUnited States
Clinical Trials on Two fiber-blend snack and four fiber-blend snack
-
Washington University School of MedicineCompletedMicrobiota | Gastrointestinal MicrobiomeUnited States
-
LOAM SciencePeople Science, Inc.Enrolling by invitationHealthy Adult ParticipantsUnited States
-
Sorridi TherapeuticsIllinois Institute of Technology, Chicago, USACompleted
-
Institut de Recherche pour le Developpement, CambodiaUNICEF; Department of Fisheries Post-harvest Technologies and Quality ControlCompleted
-
Midwest Center for Metabolic and Cardiovascular...General MillsCompletedWeight Loss | Gastrointestinal Symptoms | GLP-1United States
-
Vladimir VuksanCanadian Diabetes AssociationCompletedDiabetes Mellitus, Type 2Canada
-
Instituto Jalisciense de CancerologiaUniversity of Guadalajara; Instituto Tecnológico y de Estudios Superiores de... and other collaboratorsEnrolling by invitationBreast Cancer | Inflammatory Disease | ChemobrainMexico
-
Maastricht University Medical CenterRecruitingHyperinsulinism | Insulin Sensitivity | Glucose Metabolism Disorders (Including Diabetes Mellitus)Netherlands
-
Oregon Health and Science UniversityOhio State University; National University of Natural Medicine; University of... and other collaboratorsCompletedAttention Deficit Hyperactivity DisorderUnited States, Canada